Literature DB >> 11295426

Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.

M Ono1, Y Arano, T Mukai, T Uehara, Y Fujioka, K Ogawa, S Namba, M Nakayama, T Saga, J Konishi, K Horiuchi, A Yokoyama, H Saji.   

Abstract

6-Hydrazinopyridine-3-carboxylic acid (HYNIC) constitutes one of the most attractive reagents to prepare (99m)Tc-labeled polypeptides and peptides of various molecular weights in combination with two tricine molecules as coligands. Indeed, (99m)Tc-HYNIC-conjugated IgG showed biodistribution of radioactivity similar to that of (111)In-DTPA-conjugated IgG. However, recent studies indicated significant plasma protein binding when the (99m)Tc labeling procedure was expanded to low molecular weight peptides. In this study, pharmacokinetics of (99m)Tc-HYNIC-conjugated IgG, Fab and RC160 using tricine were compared with their radioiodinated counterparts to evaluate this (99m)Tc-labeling method. In mice, [(99m)Tc](HYNIC-IgG)(tricine)(2) and [(99m)Tc](HYNIC-Fab)(tricine)(2) showed persistent localization of radioactivity in tissues when compared with their (125)I-labeled counterparts. [(99m)Tc](HYNIC-IgG)(tricine)(2) eliminated from the blood at a rate similar to that of (125)I-labeled IgG, while [(99m)Tc](HYNIC-Fab)(tricine)(2) showed significantly slower clearance of the radioactivity than (125)I-labeled Fab. On size-exclusion HPLC analyses, little changes were observed in radiochromatograms after incubation of [(99m)Tc](HYNIC-IgG)(tricine)(2) in murine plasma. However, [(99m)Tc](HYNIC-Fab)(tricine)(2) and [(99m)Tc](HYNIC-RC160)(tricine)(2) demonstrated significant increases in the radioactivity in higher molecular weight fractions in plasma. Formation of higher molecular weight species was reduced when [(99m)Tc](HYNIC-RC160)(tricine)(2) was stabilized with nicotinic acid (NIC) to generate [(99m)Tc](HYNIC-RC160)(tricine)(NIC). [(99m)Tc](HYNIC-RC160)(tricine)(NIC) also demonstrated significantly faster clearance of the radioactivity from the blood than [(99m)Tc](HYNIC-RC160)(tricine)(2). These findings suggested that one of the tricine coligands in (99m)Tc-HYNIC-labeled (poly)peptides would be replaced with plasma proteins to generate higher molecular weight species that exhibit slow blood clearance. In addition, the molecular sizes of parental peptides played an important role in the progression of the exchange reaction of one of the tricine coligands with plasma proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295426     DOI: 10.1016/s0969-8051(00)00200-6

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  9 in total

1.  A novel ternary ligand system useful for preparation of cationic (99m)Tc-diazenido complexes and (99m)Tc-labeling of small biomolecules.

Authors:  Young-Seung Kim; Zhengjie He; Wen-Yuan Hsieh; Shuang Liu
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

2.  Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.

Authors:  Yuji Kuge; Nozomi Takai; Yuki Ogawa; Takashi Temma; Yan Zhao; Kantaro Nishigori; Seigo Ishino; Junko Kamihashi; Yasushi Kiyono; Masashi Shiomi; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

3.  Immunoglobulin G (IgG)-Based Imaging Probe Accumulates in M1 Macrophage-Infiltrated Atherosclerotic Plaques Independent of IgG Target Molecule Expression.

Authors:  Yoichi Shimizu; Hiroko Hanzawa; Yan Zhao; Sagiri Fukura; Ken-Ichi Nishijima; Takeshi Sakamoto; Songji Zhao; Nagara Tamaki; Mikako Ogawa; Yuji Kuge
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

4.  IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions.

Authors:  Signe Humle Jorgensen; Nicolas Storm; Poul Erik Hyldgaard Jensen; Henning Laursen; Per Soelberg Sorensen
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

5.  How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies.

Authors:  Robert C King; M Bashir-Uddin Surfraz; Stefano C G Biagini; Philip J Blower; Stephen J Mather
Journal:  Dalton Trans       Date:  2007-09-25       Impact factor: 4.390

6.  Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.

Authors:  Shundong Ji; Yang Zhou; Guoqiang Shao; Shuang Liu
Journal:  Bioconjug Chem       Date:  2013-04-08       Impact factor: 4.774

Review 7.  Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases.

Authors:  Kazuma Ogawa; Atsushi Ishizaki
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

8.  A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging.

Authors:  Danial Shamshirian; Mostafa Erfani; Davood Beiki; Maliheh Hajiramazanali; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

9.  A new method for radiolabeling of human immunoglobulin-G and its biological evaluation.

Authors:  Thakuri Singh; Neeraj Kumar; Sandeep Soni; Harish Rawat; Gaurav Mittal; Ajay K Singh; Aseem Bhatnagar
Journal:  J Pharm Bioallied Sci       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.